Brian Bekker Hansen

Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States

Sarah Ali, Tam Dang‐Tan, William J. Valentine et al. · Advances in Therapy · 2020 · 54 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +17

The Economic and Health-related Impact of Crohnʼs Disease in the United States

Michael L. Ganz, Rebecca Sugarman, Rosa Wang et al. · Inflammatory Bowel Diseases · 2016 · 53 citations · Full text

Public Affairs, Chronic Disease Prevention, Health Economics +16

Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK

Stephen C. Bain, Brian Bekker Hansen, Barnaby Hunt et al. · Journal of Medical Economics · 2019 · 52 citations · Full text

Pharmacy, Health Care Management, Pharmacoeconomics +17

Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme

Stephen C. Bain, Brian Bekker Hansen, Samuel J. P. Malkin et al. · Diabetes Therapy · 2019 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice Experiment

Ataru Igarashi, Brian Bekker Hansen, J Langer et al. · Advances in Therapy · 2020 · 43 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17